4-Hexylresorcinol inhibits transglutaminase-2 activity and has synergistic effects along with cisplatin in KB cells

Seong-Gon Kim
2011 Oncology Reports  
resistance to chemotherapy is very important in the prognosis of tumors. transglutaminase-2 (tg-2) mediated chemotherapy resistance has been widely reported. the objective of this study was to demonstrate the effect of 4-hexylresorcinol (4-Hr) on tg-2 activity in nasopharyngeal squamous cell carcinoma cells (KB cells). treatment with a mixture of 4-HR and cisplatin significantly decreased KB cell viability compared to treatment by cisplatin alone at 10 µg/ml (p<0.001). 4-Hr inhibited tg-2
more » ... ty compared to cisplatin alone at 5, 10 and 20 µg/ml (p=0.001, 0.001 and 0.003, respectively). nuclear translocation of tg-2 was also inhibited by 4-Hr treatment. 4-Hr treatment also increased the fluorescence life-time of DAPI significantly compared to the untreated control or the cisplatin treated group (p<0.001). In conclusion, 4-HR inhibited TG-2 activity and showed a synergistic effect on tumor cell growth inhibition with cisplatin.
doi:10.3892/or.2011.1218 pmid:21424127 fatcat:joxjaowg4ncnti7pqakmkch2ou